Seattle, WA, Aug-12, 2018 — / True Industry News / —
Molecular Diagnostics Market report 2016-2020 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Molecular Diagnostics market research report is a professional and in-depth study on the current state of Molecular Diagnostics Industry.
The Molecular Diagnostics Market research report covers the present scenario and the growth prospects of the global Molecular Diagnostics industry for 2016-2020. The report enlists several important factors, starting from the basics to advanced market intelligence which play a crucial part in strategizing.
Furthermore, in October 2017, FDA approved Roche’s cobas Zika, as first commercially-available donor screening test for Zika virus. In October 2017, QIAGEN launched the custom solution for the molecular diagnostic test, which accelerated adoption of molecular testing for life sciences and molecular diagnostics companies.
Request Sample Copy Of This Report: https://www.coherentmarketinsights.com/insight/request-sample/1545
Molecular Diagnostics market report provides key statistics on the market status of the Molecular Diagnostics manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the Molecular Diagnostics industry. The Molecular Diagnostics market report also presents the vendor landscape and a corresponding detailed analysis of the major vendors operating in the market.
Key Vendors of Molecular Diagnostics Market: Key players in the market are involved in new product launches to cater to increasing demand for molecular diagnostic. For instance, in August 2016 Abbott Laboratories introduced Alinity, a next generation system, used for immunoassay, clinical chemistry, point-of-care, hematology, blood and plasma screening, and molecular diagnostics. Some of the other key players in the global molecular diagnostics market include Hologic,Inc., Grifols, S.A., Abbott Laboratories, Qiagen N.V., F. Hoffmann-La Roche Ltd., Siemens Healthineers, Becton, Dickinson and Company, and Beckman Coulter, Inc.
Key takeaways of the Molecular Diagnostics Market:
The global molecular diagnostics market is expected to expand at a CAGR of 11.5% during the forecast period (2017–2025), owing to growth in biomarker identification and increasing awareness and adoption of precision medicine
Reagents and kits segment holds a major market share in product type, due to increasing awareness regarding early disease diagnosis and early treatment
Virology segment holds the largest revenue share among application segments, due rapid implementation of diagnostic tests for new discovered viruses. For instance, In October 2017, Hologic, Inc. received US FDA approval for the company’s Panther Fusion Paraflu Assay used for detection and differentiate of Para-influenza viruses 1, 2, 3, and 4.
Moreover, governments of various countries are focusing on initiatives, in order to develop novel techniques in precision medicines. For instance, the U.S. government launched Precision Medicine Initiative (PMI) in 2015, in order to increase awareness and focus on advancements in the precision medicine field, which in turn is expected to favor growth of the molecular diagnostics market.
Browse 37 Market Data Tables and 35 Figures spread through 176 Pages and in-depth TOC on ” Molecular Diagnostics Market, by Product Type (Reagents & Kits and Instruments), By Application (Oncology, Genetic Testing, Microbiology, STDs, Blood Screening, Virology, Tissue Typing, Prenatal Diagnosis, and Others), By End User (Hospitals, Diagnostic Laboratories, Academic and Research Labs, and Other) – Global Forecast to 2025″
Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1545